Thermo Fisher Webinars
-
mRNA-Based Therapeutics Development Through Efficient mRNA Purification
6/9/2025
Discover how a novel affinity resin simplifies and maximizes the purification of mRNA therapeutics. Learn about the scalable technique vital for commercial manufacturing.
-
Supply Resiliency For Bioprocessing Amid Global Volatility
10/2/2025
Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.
-
Driving Measurable Productivity Gains In CHO Cell Culture
8/25/2026
Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.
-
Maximizing Media Strategies: Expert Insights On Boosting Performance
5/22/2025
Optimize biopharma media strategies for consistent protein quality. Experts discuss formats, variability, and actionable analytics in this on-demand virtual roundtable.
-
Evaluating Modular CAR T Manufacturing Workflows
9/28/2026
As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.
-
Efficient mAb Development With A Flexible Purification Toolkit
6/4/2026
Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.
-
How Modular Workflows Are Redefining CAR T Manufacturing
7/30/2026
Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.
-
Maintaining Process Consistency And Performance During Scale-Up
10/22/2026
See how an intensified N-1 perfusion process maintained stable cultures, reproducible cell expansion, and aligned mAb production across 5 L, 50 L, and 500 L scales while supporting viable cell densities.
-
Fast Track Your Path To Commercialization
5/21/2025
Discover key strategies for scaling biologics from bench to pilot scale and learn how to overcome challenges in process development, including control of agitation, oxygen, CO₂, and nutrient supplementation.
-
Isolating CD4 / CD8 T Cells For Improved Drug Efficacy, Productivity
6/2/2025
Learn how the active detachment of dynabeads from target cells at any time allows users to add flexibility and scalability to their process.